Because some people have already lost weight on injectable GLP-1 medications and need a maintenance option that does not require ongoing injections
Prevalence, causes, impacts, and management of needle phobia Love & Love, J Primary Care Community Health, 2021 (11.566M U.S
503B Compounding Pharmacies Market size is anticipated to grow at a CAGR of 7.6% with USD 1,350 Mn in 2026 and is expected to reach USD 2,260 Mn in 2033
Efficacy and safety of LY3298176, a novel dual GIP and GLP1 receptor agonist, in patients with type 2 diabetes: a randomised, placebocontrolled and active comparatorcontrolled phase 2 trial
However, taking more than your prescribed amount significantly increases the risk of severe nausea, vomiting, and other complications
Selenium distribution in the Chinese environment and its relationship with human health: A review